Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Price:
0.0625 USD
4.17%
Market Closed
Updated:
Jun 2, 2024
Aridis Pharmaceuticals Inc
Accrued Liabilities
|
Aridis Pharmaceuticals Inc
Accrued Liabilities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Aridis Pharmaceuticals Inc
NASDAQ:ARDS
|
Accrued Liabilities
$10.1m
|
CAGR 3-Years
50%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Accrued Liabilities
$5.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
8%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Accrued Liabilities
$14.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Accrued Liabilities
$2.8B
|
CAGR 3-Years
22%
|
CAGR 5-Years
39%
|
CAGR 10-Years
28%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Accrued Liabilities
$2.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
28%
|
See Also
What is Aridis Pharmaceuticals Inc's Accrued Liabilities?
Accrued Liabilities
10.1m
USD
10.1m
USD
Based on the financial report for Dec 31, 2022, Aridis Pharmaceuticals Inc's Accrued Liabilities amounts to 10.1m USD.
What is Aridis Pharmaceuticals Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
37%
37%
Over the last year, the Accrued Liabilities growth was 56%. The average annual Accrued Liabilities growth rates for Aridis Pharmaceuticals Inc have been 50% over the past three years , 37% over the past five years .
You don't have any saved screeners yet
